Analytical Data
-
基因名
TMEM82
- Application
-
别名
TMEM82; Transmembrane Protein 82
-
种属
Human
-
表达系统
E. coli
-
标签
GST-tag at N-terminal
-
纯度
Greater than 90% as determined by SDS-PAGE.
-
蛋白编号
A0PJX8
-
表达区间
1-343 aa
-
氨基酸序列
MFSLPSLPSWLPGLPSLEWGSSLLDSLLQGLIGALGVLVLNSLLKVYFFVGCANDPQRRPEKERLRAQWASLETVHLAGLALFLTVVGSRVAALVVLEFSLRAVSTLLSLGKGSQGAAERLQLYLLCQYSLGCGLTCGLSFLQEGAPHRTLNLLLSLGLATLLGLGARRLHRHVCRLYELHSSQRYCGVCLGLLAHAHGLPQLLGRALAIAFAVGDLAAVALINQDFLTTSEAMRFWTPLTICYTLLVIYMQEEQRQHPGLQSQVQTVLVRMGGLFVLLLTVGRWLDLLGILVSLLGELWCLVGVRTLLDLCQIQDFPSQRPPVSTPSQPLPSAPQSQSSAPS
-
分子量
63.6 kDa
-
内毒素
< 1.0 EU per μg protein as determined by the LAL method.
-
性状
Freeze-dried powder
-
缓冲液
PBS, pH7.4, containing 0.01% SKL, 1mM DTT, 5% Trehalose and Proclin300.
-
复溶方法
Reconstitute in ddH2O to a concentration of 0.1-0.5 mg/mL. Do not vortex.
- 个性化定制
-
稳定性测试
The thermal stability is described by the loss rate. The loss rate was determined by accelerated thermal degradation test, that is, incubate the protein at 37℃ for 48h, and no obvious degradation and precipitation were observed. The loss rate isless than 8% within the expiration date under appropriate storage condition.
-
保存条件 & 期限
Samples are stable for up to twelve months from date of receipt at -20℃ to -80℃. Store it under sterile conditions at -20℃ to -80℃. It is recommended that the protein be aliquoted for optimal storage. Avoid repeated freeze-thaw cycles.
-
运输条件
In general, recombinant proteins are supplied as lyophilized powder and shipped at ambient temperature. For bulk packages, the proteins are provided as frozen liquid and shipped with blue ice, unless otherwise requested by the customer.
Quality inspection process
Related Products
Protein Description
TMEM82 (Transmembrane Protein 82) is a member of the transmembrane protein family that has garnered significant interest in recent years due to its potential roles in various cellular processes and implications in disease mechanisms. Initial studies have suggested that TMEM82 may be involved in regulating cellular signaling pathways, and it is suspected to play a role in cell proliferation, differentiation, and apoptosis. Notably, aberrant expression of TMEM82 has been linked to certain malignancies, indicating that it could serve as a biomarker for cancer progression or a potential therapeutic target. The recombinant expression of TMEM82 in suitable systems facilitates the detailed study of its structure, function, and interactions with other cellular components. By producing TMEM82 as a recombinant protein, researchers can investigate its biochemical properties, post-translational modifications, and potential interactions with other proteins or lipids. Additionally, understanding the functional mechanisms of TMEM82 may provide insights into its role in disease context, particularly in cancer. Overall, the study of TMEM82 through recombinant protein technology is essential for elucidating its biological significance, paving the way for novel therapeutic strategies targeting this protein in pathological conditions.
